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Introduction
Ceramide (Cer) is composed of long-chain aminoalcohol and amide-linked fatty acids, whose chain lengths are 18e20 and 16e24, respectively (Figure 1 ). Cer serves as a membrane constituent and also as the backbone of all complex sphingolipids. It is converted to metabolites, and Cer and its metabolites regulate cellular functions ( Figure 2 ). In skin, Cer serves as a key component in the epidermal permeability barrier in the stratum corneum. We review the signaling roles of Cer and its metabolites in skin. To distinguish between Cer forming epidermal permeability barrier structures and Cer regulating cellular function, the former and the latter are referred to as "barrier Cer" and "signaling Cer," respectively.
Ceramide for epidermal permeability barrier
An epidermal permeability barrier is required for survival of mammals living in dry terrestrial environments. Major barrier lipids consist of cholesterol, free fatty acid, and Cer, which localizes in the extracellular lipids in the stratum corneum and is a key permeability barrier constituent. At least nine molecular classes of Cer, in both bulk amounts and molecular heterogeneity, located in the stratum corneum are unique to skin. 1, 2 Prior studies show that decreased contents of Cer and/or alteration of molecular species occur in some cutaneous diseases associated with permeability barrier abnormality, i.e., atopic dermatitis (AD), psoriasis, and certain ichthyoses. 3e5 Furthermore, it has been recently demonstrated that a minor Cer metabolite species, sphingosine, also contributes to form a competent permeability barrier structure. 6, 7 Conflicts of interest: The authors declare that they have no financial or nonfinancial conflicts of interest related to the subject matter or materials discussed in this article.
Differences between Cer for epidermal permeability barrier and Cer for signaling
The differences between Cer responsible for permeability barrier formation in the stratum corneum and signaling Cer are summarized below.
(1) Localization. As stated above, barrier Cer is localized in the extracellular spaces in the stratum corneum. In contrast, signaling Cer regulates cellular function on the plasma membrane or intracellular compartment in cells, including nuclear layers of epidermal keratinocytes. (2) Content. Cer in the stratum corneum is present in millimolar quantities, which contribute to form the epidermal permeability barrier, 8 whereas plasma membrane or intracellular Cer has micromolar levels. (3) Molecular species. Heterogeneous molecules of Cer are present in the stratum corneum, and such heterogeneity is required for formation of uniform lamellar membrane structures. It has been shown that Cer species that consist of N-nonhydroxyl fatty acid and sphingosine can regulate biological processes. Certain Cer species (chain lengths of amide-linked fatty acid 16) lack antimitogenic or proapoptotic features, which leads to increased apoptosis in squamous cell carcinoma cells in response to endoplasmic reticulum (ER) stress. However, the structure requirements of signaling Cer are largely unknown.
Ceramide metabolites
Cer is converted into four metabolic pathways ( Figure 3 ).
(1) Choline phosphorylated to sphingomyelin by sphingomyelin synthase 1 or sphingomyelin synthase 2. The former is localized in the trans Golgi apparatus and latter is in the plasma membrane. (2) Glycosylated to glucosylceramide by UDP-glucosyltransferase or galactosylceramide by UDP-galactosyltransferase to synthesize glucosylceramide and galactosyloceramide, respectively. Glucosylceramide, but not galactosylceramide, is synthesized in epidermal keratinocyte. Four isoforms of ceramidased(1) acidic ceramidase distributed in lysosome; (2) neutral ceramidase in plasma membrane and ER;
(3) alkaline ceramidase 2 (so-called skin ceramidase) in ER and alkaline ceramidase 3 in Golgi apparatus; (4) phytoalkaline ceramidase (alkaline ceramidase 1) in ERdhave been identified in mammals. Alkaline ceramidase 2 has been shown only in differentiated layers in the epidermis. Four ceramidase isoforms are present in keratinocytes, whereas both acidic and alkaline ceramidase 2 levels are increased and alkaline ceramidase 1 levels are decreased during keratinocyte differentiation. 1 The other three ceramidase levels are not changed in a differentiation-dependent manner. Moreover, glycosylceramides are further glycosylated to di-or polyglycosylceramide. In the epidermis, glucosylceramides are a major species. Sphingosine is phospholyated to sphingosine-1-phosphate (S1P) by sphingosine kinase 1 or 2.
Glucosylceramide is hydrolyzed to glucose and ceramide by bglucocerebrosidase, whereas sphingomyelin is hydrolyzed to sphingosine and phosphorylcholine by sphingomyelinase.
Signaling Cer can be produced from hydrolyses of sphingomyelin or glucosylceramide, by sphingomyelinase or b-glucocerebrosidase, respectively, as well as de novo synthesis by activation of either serine-palimitoyltransferase or ceramide synthase. 1, 9 In contrast to the sphingomyelin pathway that generates signaling Cer, the glucosylceramide pathway has not been elucidated. Our prior studies demonstrated that Cer production is increased following ultraviolet (UV) B irradiation or other oxidative stressors and results in increasing Cer-induced apoptosis in keratinocytes. 10 Both toxic (high doses) and subtoxic (low doses) increased ceramide, whereas toxic levels of irradiation sustained elevated Cer; however, Cer was restored toward normal levels in cells treated with subtoxic levels of UVB because of its efficient conversion into nonapoptotic Cer metabolites, 10 suggesting that metabolic conversion contributes to protecting cells against Cer-induced apoptosis. Cer-induced apoptosis is in part a mechanism of chemotherapy, whereas accelerating metabolic conversion of Cer to glucosylceramide and S1P-attenuating chemotherapy has been shown in several types of tumor cells, including melanoma. In particular, the chemotherapy-resistant tumor cells often show increased enzyme production, which is responsible for the metabolic protective mechanism against Cer-induced apoptosis. 11, 12 Cer signaling roles that regulate cellular functions
The first demonstration of a Cer signaling role (to induce erythroblast maturation) was in 1974. The first barrier Cer studies, reported in 1975 by Gray and Yardley, 13 initiated the field of skin Cer research. In contrast, Cer signaling studies were not further developed for some time. In early 1990, it was shown that increasing cellular Cer levels by sphinomyelinase activation induced cell cycle arrest and differentiation in leukemia cells in response to vitamin D or phorbol ester. 14, 15 A technical difficulty of Cer biological studies is the poor solubility of Cer in aqueous solution. The application of cell-permeable short-chain amide-linked fatty acid (C2eC8) containing Cer, which substantially increased hydrophilicity, has led to more signaling Cer studies. Although such short-chain Cer is not synthesized in mammalian cells, it can be used as a precursor to synthesize natural, long-chain Cer in cells. 16 Previous studies demonstrated that, in response to various stimuli, including ER stress, sphingomyelin hydrolysis by sphingomyelinase activation and/or de novo synthesis of Cer by ceramide synthase activation generate signaling Cer. 17e19 Cer mechanisms that regulate cellular functions depend on cell types and/or stimuli. 12, 20 The following downstream mechanisms have been demonstrated in mammalian cells:
(1) Increased cellular Cer activates ceramide-activating serine/ threonine phosphatases (CAPS)di.e., protein phosphatase 1A (PP1A) and protein phosphatase 2A (PP2A), 21 protein kinase C (PKC) z, 22 cathepsin D, 23 and kinase suppressor RAS. 24 (2) CAPS, PP1A, and PP2A inactivate PKCa, 25 and AKT [or protein kinase B (PFB)], 26 depending on cell and tissue types as well as stimuli.
In addition to these mechanisms, Cer physically affect cellular functions. Cer permeabilizes mitochondrial outer membranes, leading to mitochondrial-mediated apoptosis. 27 Signaling roles of Cer metabolites in regulation of antimicrobial peptide production Skin deploys multiple barriers to protect cells and tissues from external perturbationsdi.e., UV/oxidative stress, mechanical stress, and microbial infection. The antimicrobial peptide (AMP), an innate immune component, is a key constituent of the antimicrobial barrier. Microbial infection increases AMP production, whereas diverse types of external perturbationsdsuch as epidermal permeability disruption, UV irradiation, and other types of oxidative stressd stimulate key epidermal AMP [cathelicidin antimicrobial peptide (CAMP), human beta-defensin (hBD) 1, hBD2 and hBD3 production]. Although all perturbations increase the risk of microbial infections, AMP production is increased in skin without infections following perturbations. Our recent studies demonstrate that acute epidermal permeability defects, as well as UVB/oxidative stress induce ER stress in keratinocytes. 28, 29 The ER is an intracellular organelle that synthesizes protein and lipid, and is a major storage place for Ca 2þ . ER stress occurs in cells when proteins are accumulated and Ca 2þ is released from the ER. Three major transmembrane proteinsdinositol-requiring enzyme 1 (IRE1 or ERN1, a kinase with ribonuclease activity), protein kinase RNA-like endoplasmic reticulum kinase (PERK; also known as PEK or EIF2AK3), and activating transcription factor 6dserve as sensors of ER stress and also induce rescue signals to restore cellular function, because ER stress causes deleterious cell effects, including apoptosis. 30 However, high levels of ER stress levels cause apoptosis. We found that ER stress stimulates both CAMP and hBD2 and hBD3, but not hBD1, production. 31, 32 These studies demonstrate how different external perturbations can increase specific AMP production through one mechanism.
CAMP production CAMP is a multifunctional AMP that is not only antimicrobial, but also accelerates cell growth, cell motility, angiogenesis, and certain cytokine production. 33, 34 As discussed above, CAMP production is stimulated following external perturbation that can induce ER stress in parallel with increasing cellular Cer production. Prior studies characterized that a nuclear hormone receptor, vitamin D receptor (VDR), is dependent on the stimulation of CAMP production. 35 Microbial infection activates Toll-like receptor 2. Toll-like receptor 2 does not activate VDR, but does activate 25-hydroxy vitamin D 3 1-alpha-hydroxylase (CYP27B1), which synthesizes a VDR ligand 1a, 25-dihydroxy vitamin D 3 , leading to stimulation of CAMP production. VDR binding sequence has not been identified on the promoter region of binding sequence on a murine CAMP (CRAMP) gene, 35 as opposed to the human CAMP gene. Importantly, we found that VDR transcription activity is suppressed in cells under ER stress, and VDR gene silencing does not alter increased CAMP production. 28 Recent studies further identified that a Cer metabolite, S1P, activates transcription factor nuclear factor-kappa B (NF-kB). 31 The NF-kB binding sequence is not identified on a CAMP promoter. 28, 35 NF-kB then activates another transcription factor C/EBPa (by MAP kinase activation) that stimulates CAMP transcription 28 (Figure 4) . S1P-mediated signaling of cellular functions is often dependent on prior binding to one or more of five known G-protein-coupled S1P receptors (S1P1eS1P5), located on the outer surface of the plasma membrane. 36 KC express all five receptors. 37 However, S1P activates NF-kB via the S1P receptor-independent pathway intracellular region. 31 hBD2 and hBD3 production Both hBD2 and hBD3 are stimulated by microbial infections, whereas upstream mechanisms to regulate these hBDs are different. Proinflammatory cytokines (interleukin-1b, tumor necrosis factor-a, interferon-g) induce hBD-2 mRNA transcription by activation. 38 hBD3 production is induced by epidermal growth factor receptor activation. 39 Other transcriptional factors, signal transducer and activator of transcription (STAT) 1 and STAT 3, also serve as downstream signals to regulate hBD2 and hBD 3 transcription. 40, 41 Recent studies have shown that C1P is increased following increased Cer production, in response to external perturbation and ER stress. 32 C1P directly activates cytosolic phospholipase A2 to rerelease arachinonate from glycerophospholipids, leading to increased eicosanoid production, including PGE2 and PGJ2. Prior study showed that C1P-mediated, elevated PGE2 levels increase inflammatory responses in cells. 42 C1P also increased PGJ2 production followed by stimulation of hBD2 and hBD3 production. 32 PGJ2 is an activator of nuclear hormone receptors, peroxisome proliferator-activated receptors (PPAR) a, PPAR b/d, and PPARg. 43 C1P stimulates hBD2 and hBD3 production through PPARa and PPARb/ddbut not PPARgdactivation. 32 Then, PPARa and PPARb/d activate STAT1 and STAT 3 via the activation of tyrosine Src kinase. STAT 1 and STAT 3 are activated by phosphorylation that binds to promoter sequences of hBD2 or hBD3, leading to hBD2 and hBD3 production 32 ( Figure 5 ).
Pharmacological modulation and clinical implication of CAMP production
Recent studies have demonstrated that certain naturally occurring polyphenolic compounds, such as stilbenoid, resveratrol, and the soy-derived isoflavone, genistein, increase cellular levels of S1P that signal to stimulate production of the key epidermal AMP, CAMP. 44, 45 Resveratrol and genistein increased S1P production via different signaling mechanisms ( Figure 6 ): (1) resveratrol increased not only ceramide, but also its key metabolites, sphingosine and S1P; (2) genistein increased production of S1P (without changes in ceramide levels) by inhibiting the activity of S1P lyase, an enzyme catalyzing S1P breakdown to phosphoethanolamine and hexadecenal, as well as increasing expression of key enzymesde.g., acidic/alkaline ceramidases and sphingosine kinase 1 (SPHK1), which convert ceramide to S1P. In addition to both naturally occurring compounds, our more recent studies suggested that direct activation of SPHK1 with a chemically synthesized compound, (S)-methyl 2-(hexanamide)-3-(4-hydroxyphenyl) propanoate (defensamide), can also stimulate CAMP production via our Figure 4 Ceramide metabolite, sphingosine-1-phosphate signals to stimulate cathelicidin antimicrobial peptide (CAMP) production. Figure 5 Ceramide metabolite, ceramide-1-phosphate signals to stimulate human beta-defensin (hBD) 2 and hBD3 production.
identified S1P-dependent mechanism (unpublished data) ( Figure 6 ). These studies indicate multiple target points whereby naturally occurring or chemically synthesized compounds increase production of S1P that could enhance antimicrobial defense through the stimulation of CAMP production. 44, 45 In addition, curcumin stimulates CAMP production via the VDRindependent pathway. 46 Because patients with AD do not produce enough CAMP in response to microbial pathogens, bacterial infections are a serious and frequent complication of AD patients. Therefore, these individual compounds, which can stimulate CAMP production, are potentially useful for the development of novel potential therapeutic agents and/or cosmetic products to enhance antimicrobial defense in AD.
Conclusion
Cer and its metabolites exhibit multifunctions in mammalian cells, including keratinocytes. In contrast to barrier Cer, even a 1/1000 part of Cer concentration will suffice to generate signals to alter cellular function. Because such a small change occurs in certain cellular compartment(s) and/or basal Cer, S1P, and C1P levels are low, increased levels of Cer or its metabolites could have a great impact on cells. A rescue mechanism, metabolic conversion, against Cer-induced apoptosis enhances innate immunity through AMP production. Hormesis shows that low levels of external perturbations, including radiation, and oxidative stress, enhance the cellular antioxidant system (superoxide dismutase) and thioredoxin, a tumor suppressor gene p53, and heat shock proteins. 47 Similarly, low levels of Cer and its metabolites could enhance defense against these external perturbants in cells.
